IRIS
VIGNERI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.422
EU - Europa 3.886
AS - Asia 3.577
SA - Sud America 710
AF - Africa 480
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 17.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.154
SG - Singapore 1.527
IT - Italia 1.459
CN - Cina 1.181
IE - Irlanda 765
BR - Brasile 649
UA - Ucraina 571
IN - India 404
CI - Costa d'Avorio 309
DE - Germania 286
CA - Canada 241
RU - Federazione Russa 168
KR - Corea 154
NL - Olanda 112
SN - Senegal 112
BE - Belgio 107
GB - Regno Unito 101
VN - Vietnam 82
SE - Svezia 68
FI - Finlandia 64
BD - Bangladesh 38
CZ - Repubblica Ceca 34
FR - Francia 33
PL - Polonia 29
JP - Giappone 26
AR - Argentina 22
UZ - Uzbekistan 22
CH - Svizzera 20
HK - Hong Kong 20
NG - Nigeria 18
IQ - Iraq 17
ES - Italia 16
MX - Messico 16
GR - Grecia 15
AT - Austria 14
IR - Iran 14
TR - Turchia 14
IL - Israele 12
EC - Ecuador 10
MA - Marocco 10
LB - Libano 9
ZA - Sudafrica 9
AE - Emirati Arabi Uniti 8
PK - Pakistan 8
CO - Colombia 7
KE - Kenya 7
OM - Oman 7
SA - Arabia Saudita 7
AU - Australia 6
BG - Bulgaria 6
TN - Tunisia 6
AZ - Azerbaigian 5
VE - Venezuela 5
AL - Albania 4
CL - Cile 4
EG - Egitto 4
EU - Europa 4
ID - Indonesia 4
JO - Giordania 4
PY - Paraguay 4
RS - Serbia 4
BO - Bolivia 3
KZ - Kazakistan 3
LT - Lituania 3
PE - Perù 3
CR - Costa Rica 2
JM - Giamaica 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
RO - Romania 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GL - Groenlandia 1
HU - Ungheria 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SR - Suriname 1
TH - Thailandia 1
TW - Taiwan 1
Totale 17.091
Salva come PNG Salva come JPEG
Città #
Dallas 1.539
Santa Clara 1.358
Singapore 974
Chandler 840
Dublin 764
Jacksonville 646
Chicago 518
Catania 410
Kochi 337
Boardman 333
Hefei 316
Abidjan 309
Ashburn 210
Cambridge 206
Lawrence 203
Nanjing 200
Andover 193
Toronto 157
Seoul 153
Grafing 134
Los Angeles 127
Beijing 118
Dakar 112
Des Moines 111
San Mateo 100
Civitanova Marche 98
Wilmington 86
New York 70
Munich 63
Rotterdam 56
Ottawa 54
Palermo 54
Nanchang 51
Milan 50
Wingene 50
Hebei 47
Rome 47
Shenyang 45
São Paulo 45
Dong Ket 40
Saint Petersburg 38
Bremen 34
Brussels 34
Council Bluffs 33
Portland 33
The Dalles 32
Seattle 31
Changsha 30
Columbus 30
Jiaxing 30
Brno 28
Falls Church 26
Tianjin 26
Tokyo 26
Bari 25
Turku 25
Brooklyn 24
Rio de Janeiro 23
San Giovanni la Punta 23
Hanoi 22
Lappeenranta 22
Hong Kong 19
Moscow 19
Warsaw 19
Abuja 18
Messina 18
San Francisco 18
Belo Horizonte 17
Pune 17
Boston 16
Helsinki 16
Quintano 16
Atlanta 15
Brasília 14
Florence 14
Houston 14
Jinan 14
Manchester 14
Aci Catena 13
Bernareggio 13
Frankfurt Am Main 13
Hangzhou 13
Santa Venerina 13
Verona 13
Augusta 12
Chennai 12
Curitiba 12
Dhaka 11
Kunming 11
Leawood 11
Montreal 11
Nijmegen 11
Norwalk 11
Woodbridge 11
Ardabil 10
Giarre 10
Gioiosa Marea 10
Ho Chi Minh City 10
Miami 10
Ningbo 10
Totale 12.348
Salva come PNG Salva come JPEG
Nome #
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 211
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications 176
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 171
148P The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy 166
A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal Melanomas 157
Correlation between weight and Recurrence Score in a cohort of HR+ve/ HER2-ve early breast cancer patients: a retrospective analysis 155
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 124
Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review 124
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 120
Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series 118
Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release 118
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny 116
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 116
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 115
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 114
Diagnostic utility of the immunohistochemical expression of serin and arginine rich splicing factor 1 (Srsf1) in the differential diagnosis of adult gliomas 113
Biomarkers and prognostic factors for malignant pleural mesothelioma 108
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 106
Comparative proteomic analysis of insulin receptor isoform A and B signaling 106
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 104
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 103
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 103
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 100
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 99
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 97
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA 96
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer 95
Heavy metals in the volcanic environment and thyroid cancer 94
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein 94
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 94
BCR-ABL Tyrosine Kinase Activity Modulates the Phosphorylation, Localization and Function of Interferon Regulatory Factor 5 (irf-5) in Chronic Myeloid Leukemia (CML) Cells 93
New insights in thyroid cancer and p53 family proteins 93
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part I: MR imaging with pathologic correlation and technical considerations 93
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 92
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND FUNCTION OF INTERFERON REGULATORY FACTOR 5 (IRF-5) IN CHRONIC MYELOID LEUKEMIA CELLS 91
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature 89
AN INSERTION IN THE BCR-ABL KINASE DOMAIN CONTRIBUTES TO IMATINIB MESYLATE RESISTANCE 89
BCR-ABL tyrosine kinase activity modulates the phosphorylation and the localization of Interferon Regulatory Factor 5 (IRF-5)in Chronic Myeloid Leukemia cells 89
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 88
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 88
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 88
Computational and Experimental Characterization of Two Nuclear Localization Signals and a Nuclear Export Signal that modulate BCR intracellular localization 87
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 87
Suppression of survivin induced by BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs 86
BCR-Abl tyrosine kinase activity modulates the expression of Interferon Regulatory Factor-5 in CML cells 86
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part II: treatment indications and complications 86
Orbital metastasis from thyroid cancer: a case report and review of the literature 85
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 85
Insulin receptor isoforms differently regulate cell proliferation and apoptosis in the ligand‐occupied and unoccupied state 85
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 85
BCR-ABL tyrosine kinase activity modulates survivin expression via PI3K/AKT 84
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND BIOLOGICAL FUNCTION OF INTERFERON REGULATORY FACTOR 5 IN CHRONIC MYELOID LEUKEMIA CELLS 83
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 83
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report 83
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 83
Histopathologic and mr imaging appearance of spontaneous and radiation-induced necrosis in uveal melanomas: Initial results 83
Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions 83
Unsuccessful dasatinib therapy in a refractory patient with chronic lymphocytic leukemia 82
Uncommon long-term survival in a patient with chronic myeloid leukemia 82
ENDOMETRIAL STROMAL TUMOR (SARCOMA) WITH LIMITED MIOMETRIAL INFILTRATION: A RARE CASE WITH PELVI-PERITONEAL METASTASES 82
Cerebellar liponeurocytoma: clinical, histopathological and molecular features of a series of three cases, including one recurrent tumor 82
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 81
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 81
c-IAP1, Survivin and Smac contribute to chemotherapy resistance in undifferentiated thyroid cancer cells 81
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 81
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma 81
Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease 81
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 81
Increased thyroid cancer incidence in volcanic areas: A role of increased heavy metals in the environment? 81
p73 tumor-suppressor activity is impaired in human thyroid cancer 80
Vg9Vd2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells 80
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 80
Late Breaking Abstract - Comparison of VATS debulking surgery and HITHOC vs VATS talc pleurodesis alone in malignant pleural mesothelioma: a pilot study 80
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas 80
BCR-ABL tyrosine kinase activity modulates Survivin expression in CML cells 79
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression 79
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 79
Hypoxia Induces Imatinib Resistance in CML Cell Lines 78
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 78
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 78
Heavy Metals in the Environment and Thyroid Cancer 77
RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features 77
The p53-homologue p63 may promote thyroid cancer progression 76
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors 75
Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase 75
Several site-specific cancers are increased in the volcanic area in Sicily 75
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. 75
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 74
Increased phospho-mTOR expression in megakaryocytic cells derived from CD34+ progenitors of essential thrombocythaemia and myelofibrosis patients 74
Differences among young adults, adults and elderly chronic myeloid leukemia patients 74
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity 74
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 74
Interplay between Kinase Domain Autophosphorylation and F-Actin Binding Domain in Regulating Imatinib Sensitivity and Nuclear Import of BCR-ABL 73
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 73
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 72
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma 72
FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case Series 72
The optimal timing between neoadjuvant therapy and surgery of breast cancer: a brief systematic review of the literature 71
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 71
The PU.1 transcription factor induces cyclin D2 expression in U937 cells 71
Totale 9.282
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.885
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.146 0 0 140 15 304 36 136 6 233 4 185 87
2021/20221.496 155 202 22 20 229 37 223 49 136 28 56 339
2022/20232.775 228 144 58 296 208 462 32 540 633 20 94 60
2023/20241.443 108 220 52 78 76 257 34 86 10 67 268 187
2024/20255.951 159 869 311 258 1.148 686 255 185 364 460 780 476
2025/20263.155 736 720 1.699 0 0 0 0 0 0 0 0 0
Totale 17.506